• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY:MRK)

    113.41 -0.04 (-0.04%)
    Official Closing Price Updated: 6:30 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,283,153
    Open 113.63
    Bid (Size) 112.33 (400)
    Ask (Size) 113.85 (100)
    Prev. Close 113.45
    Today's Range 112.56 - 113.90
    52wk Range 73.31 - 125.14
    Shares Outstanding 2,531,374,696
    Dividend Yield 3.00%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
    Investors can find much better opportunities. 
    Via The Motley Fool
    Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
    Via Investor Brand Network

    Performance

    YTD
    +6.5%
    +6.5%
    1 Month
    -5.6%
    -5.6%
    3 Month
    -4.9%
    -4.9%
    6 Month
    +24.0%
    +24.0%
    1 Year
    +48.0%
    +48.0%

    More News

    Read More
    InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
    Via Investor Brand Network
    Merck & Co. Inc. (NYSE:MRK): A High Dividend Rating Backed by Strong Profitability and Financial Health ↗
    Via Chartmill
    Merck (NYSE:MRK) Q1 2026 Results Show Underlying Strength Despite Acquisition-Driven Loss ↗
    Via Chartmill
    News headline image
    Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
    From BioMedWire
    Via GlobeNewswire
    News headline image
    1 Dividend ETF Quietly Outperforming the Market Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence ETFs Stocks
    News headline image
    2 Cash-Producing Stocks to Research Further and 1 Facing Challenges
    Via StockStory
    Topics Credit Cards
    News headline image
    Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    2 Dividend Stocks to Double Up On Right Now ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy? ↗
    Via The Motley Fool
    News headline image
    The Top 5 Analyst Questions From Merck’s Q1 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    Merck Animal Health Selects Salesforce’s Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees
    From Salesforce
    Via Business Wire
    News headline image
    Tempus AI (TEM) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    3 Monster Dividend Stocks That Could Pay You Through the Next Decade of Chaos ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    What's going on in today's pre-market session: S&P500 movers ↗
    Via Chartmill
    News headline image
    MRK Q1 Deep Dive: Oncology Strength, New Launches, and Pipeline Milestones Define Quarter
    Via StockStory
    Top S&P500 movers in Thursday's after hours session ↗
    Via Chartmill
    News headline image
    Merck (MRK) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Merck (NYSE:MRK) Surprises With Q1 CY2026 Sales
    Via StockStory
    News headline image
    Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    Merck (MRK) Q1 Earnings Report Preview: What To Look For
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke
    From Merck & Co., Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Merck & Co publicly traded?
    Yes, Merck & Co is publicly traded.
    What exchange does Merck & Co trade on?
    Merck & Co trades on the New York Stock Exchange
    What is the ticker symbol for Merck & Co?
    The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
    What is the current price of Merck & Co?
    The current price of Merck & Co is 113.41
    When was Merck & Co last traded?
    The last trade of Merck & Co was at 05/14/26 06:30 PM ET
    What is the market capitalization of Merck & Co?
    The market capitalization of Merck & Co is 287.08B
    How many shares of Merck & Co are outstanding?
    Merck & Co has 287B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.